Valion Bio Depreciation & Amortization Growth & History (VBIO)

Valion Bio's depreciation and amortization was $5,000 for fiscal 2025.

View full Valion Bio company overview

Valion Bio annual depreciation and amortization history

Valion Bio annual depreciation and amortization

Fiscal yearPeriod endedDepreciation and amortizationChangeGrowth
20252025-12-31$5,000$2,000+66.67%
20242024-12-31$3,000−$5,000−62.50%
20232023-12-31$8,000−$2,000−20.00%
20222022-12-31$10,000$2,000+25.00%
20212021-12-31$8,000

Valion Bio depreciation and amortization trends

Between the periods ended 2021-12-31 and 2025-12-31, Valion Bio's depreciation and amortization decreased from $8,000 to $5,000, a change of −$3,000. The latest reported quarter, Q2 2026, shows $358,000.

About the metric

What depreciation and amortization mean

Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.

Calculation and source

Reported depreciation and amortization

TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Valion Bio source filings ↗

Community posts

It’s quiet here.

No posts about VBIO yet. Start the conversation.

Write the first post